Uzorka JW[au] - Search Results

Year	Number of Results
2017	3
2018	2
2019	3
2020	1
2022	2

1

Prediction and prevention of tuberculosis in contacts.

Arend SM, Uzorka JW. Arend SM, et al. Among authors: uzorka jw. Lancet Infect Dis. 2017 Dec;17(12):1237. doi: 10.1016/S1473-3099(17)30640-0. Lancet Infect Dis. 2017. PMID: 29173881 No abstract available.

2

New developments on interferon-γ release assays for tuberculosis diagnosis.

Arend SM, Uzorka JW. Arend SM, et al. Among authors: uzorka jw. Lancet Infect Dis. 2019 Feb;19(2):121-122. doi: 10.1016/S1473-3099(18)30651-0. Epub 2019 Jan 14. Lancet Infect Dis. 2019. PMID: 30655048 No abstract available.

3

Tuberculosis after a borderline QuantiFERON result during screening before infliximab.

Uzorka JW, Delfos NM, Witte AMC, Scheper H, van Soolingen D, Arend SM. Uzorka JW, et al. Eur Respir J. 2018 Aug 2;52(2):1800913. doi: 10.1183/13993003.00913-2018. Print 2018 Aug. Eur Respir J. 2018. PMID: 30072541 Free article. No abstract available.

4

Discordant results of tests for tuberculosis reconsidered.

Arend SM, Uzorka JW. Arend SM, et al. Among authors: uzorka jw. Lancet Infect Dis. 2022 Feb;22(2):164. doi: 10.1016/S1473-3099(21)00807-0. Lancet Infect Dis. 2022. PMID: 35092786 No abstract available.

5

Biomarkers to identify Mycobacterium tuberculosis-infection among borderline QuantiFERON results.

Uzorka JW, Bakker JA, van Meijgaarden KE, Leyten EMS, Delfos NM, Hetem DJ, Kerremans J, Zwarts M, Cozijn S, Ottenhoff THM, Joosten SA, Arend SM. Uzorka JW, et al. Eur Respir J. 2022 Jan 20:2102665. doi: 10.1183/13993003.02665-2021. Online ahead of print. Eur Respir J. 2022. PMID: 35058249

6

Borderline QuantiFERON results and the distinction between specific responses and test variability.

Uzorka JW, Bossink AWJ, Franken WPJ, Thijsen SFT, Leyten EMS, van Haeften AC, Doornenbal G, Boonstra P, Ottenhoff THM, Arend SM. Uzorka JW, et al. Tuberculosis (Edinb). 2018 Jul;111:102-108. doi: 10.1016/j.tube.2018.06.002. Epub 2018 Jun 7. Tuberculosis (Edinb). 2018. PMID: 30029893 Free article.

7

Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.

Uzorka JW, Duinkerk DL, Kroft LJM, Bakker JA, Ramai RSRS, Ottenhoff THM, Arend SM. Uzorka JW, et al. Eur J Clin Microbiol Infect Dis. 2020 Jul;39(7):1329-1337. doi: 10.1007/s10096-020-03850-7. Epub 2020 Feb 20. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32076881 Free PMC article.

8

Abnormalities suggestive of latent tuberculosis infection on chest radiography; how specific are they?

Uzorka JW, Kroft LJM, Bakker JA, van Zwet EW, Huisman E, Prins C, van der Zwan CJ, Ottenhoff THM, Arend SM. Uzorka JW, et al. J Clin Tuberc Other Mycobact Dis. 2019 Jan 25;15:100089. doi: 10.1016/j.jctube.2019.01.004. eCollection 2019 May. J Clin Tuberc Other Mycobact Dis. 2019. PMID: 31720416 Free PMC article.

9

Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis.

Uzorka JW, Wallinga J, Kroft LJM, Ottenhoff THM, Arend SM. Uzorka JW, et al. Open Forum Infect Dis. 2019 Jul 1;6(7):ofz313. doi: 10.1093/ofid/ofz313. Open Forum Infect Dis. 2019. PMID: 31363778 Free PMC article.

10

Proof of concept that most borderline Quantiferon results are true antigen-specific responses.

Uzorka JW, Kroft LJM, Bakker JA, van Zwet EW, Huisman E, Knetsch-Prins C, van der Zwan CJ, Ottenhoff THM, Arend SM. Uzorka JW, et al. Eur Respir J. 2017 Nov 16;50(5):1701630. doi: 10.1183/13993003.01630-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29146607 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results